Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Neuropharmacology. 2022 Aug 22;218:109233. doi: 10.1016/j.neuropharm.2022.109233

Fig. 6.

Fig. 6.

ELB00824 effect on genes related to oxidative stress Relative genes expression on Spinal cord and DRG isolated from mice treated 5 consecutive days with oxaliplatin (Control), oxaliplatin + ELB (30 mg/kg), or oxaliplatin + Pioglitazone (PIO, 30 mg/kg), measured by qRT-PCR. Bars represent fold change relative to Gapdh (mean ± SEM) for each gene expression in DRG or spinal cord. One-way ANOVA revealed a significant difference between Control and oxaliplatin + ELB; *p < 0.05, **p < 0.005.